The impact of next generation sequencing (NGS) preimplantation genetic diagnostics (PGD) on pregnancy rate of frozen blastocyst embryo transfer.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2014062318202N1

Enrollment

Registered

2014-07-10

Start date

2014-08-01

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility. Female infertility, unspecified

Interventions

Next Generation Sequencing Preimplantation Genetic Diagnosis embryo selection.

Diagnosis

Next Generation Sequencing Preimplantation Genetic Diagnosis embryo selection

Eligibility

Sex/Gender

All

Age

33 Years to 42 Years

Inclusion criteria

Inclusion criteria: Incusion: 1. Patients undergoing assisted reproductive treatment with intracytoplasmic sperm injection and frozen blastocyst embryotransfer in Invicta Fertility and Reproductive Centre s. z o.o. in time frame from 08.2014 to 09.2014 Exclusion: 1. Blastocysts in stages 2CC, 3CC, 4CC, and 5CC did not qualify for biopsy. 2.Patients in whom no normal embryo was available

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Pregnancy rate. Timepoint: on 6 weeks and 1-3 days. Method of measurement: clinical poregnancy (as ultrasound fetal heartbeat detection).	—

Secondary

Measure	Time frame
Implantation rate. Timepoint: 7 day after tansfer. Method of measurement: blood serum beta-HCG concentration.	—

Countries

Poland

Contacts

Public ContactJudyta Zabielska

Invicta Gdansk

judyta.zabielska@invicta.pl0048585858800

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026